Progyny, a NYC-based digital healthcare company, secured $14.7m in Series B financing.
Backers reportedly included Kleiner Perkins Caufield and Byers, SR One and TPG Biotech.
The copmpany will use the funds to accelerate the growth of its proprietary technology and its fertility benefits solution to enterprise customers, to launch new products and services including a new app.
Led by Gina Bartasi, Chief Executive Officer, and George Nassef, Chief Technology Officer, Progyny provides a digital healthcare company combining data, science and technology to provide proactive fertility solution for both large, self-insured employers and consumers. Its SMART™ Cycle plan design comprises research and clinical solutions, including proprietary (Eeva) technology, to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs.
The company also has operations in San Francisco and Menlo Park, CA.